ConductScience.org, home

Paper58143

Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil.

Mavligit GM and 11 others. Lancet, 1976. Cited by 86 papers, by iCite.

Cite this record

ConductScience Library. Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Papers, record 58143. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/58143

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil.
PubMed
Journal
Lancet
PubMed
Year
1976
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
2.87
iCite
Revised in PubMed
2019-06-10
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mavligit GMG M
2Gutterman JUJ U
3Burgess MAM A
4Khankhanian NN
5Seibert GBG B
6Speer JFJ F
7Jubert AVA V
8Martin RCR C
9McBride CMC M
10Copeland EME M
11Gehan EAE A
12Hersh EME M

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Colonic NeoplasmsMajor topic
FluorouracilMajor topic
Postoperative CareMajor topic
Rectal NeoplasmsMajor topic
Administration, Oral
Evaluation Studies as Topic
Follow-Up Studies
Humans
Lymphatic Metastasis
Mesentery
Neoplasm Recurrence, Local
Prognosis
Time Factors

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
42437062BCG in the fight against cancer: exploring its applications in diverse tumour types and future directions.Ecancermedicalscience2026https://conductscience.org/library/papers/42437062PubMed
35477416Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy.J Hematol Oncol2022https://conductscience.org/library/papers/35477416PubMed
6925985The immunopathological effects of intracolonic injection of Mycobacterium bovis BCG cell wall emulsions in guinea pigs.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6925985PubMed
3630193Adjuvant treatment in colorectal cancer: an update.World J Surg1987https://conductscience.org/library/papers/3630193PubMed
791447Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.Br Med J1976https://conductscience.org/library/papers/791447PubMed
633274Recent advances in cytotoxic therapy for gastrointestinal carcinoma: a review.J R Soc Med1978https://conductscience.org/library/papers/633274PubMed
602232Immunotherapy as an adjunct to surgery in the treatment of cancer.World J Surg1977https://conductscience.org/library/papers/602232PubMed
443905The clinical correlation of an autopsy study of recurrent colorectal cancer.Ann Surg1979https://conductscience.org/library/papers/443905PubMed
338105Adjuvant liver perfusion in colorectal cancer: initial results of a clinical trial.Br Med J1977https://conductscience.org/library/papers/338105PubMed
323119Immunoprophylaxis and therapy of grafted rat colonic carcinoma.Gut1977https://conductscience.org/library/papers/323119PubMed
272083Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.World J Surg1977https://conductscience.org/library/papers/272083PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/58143

GET https://conductscience.org/api/papers/v1/58143/authors